Citadel Securities Starts Savient Pharmaceuticals (SVNT) at Add, Sees Much Potential For an Upside
Tweet Send to a Friend
Citadel Securities initiates coverage on shares of Savient Pharmaceuticals (NASDAQ: SVNT) with an Add rating and a $14 price target.
This article: 202 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 202 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
